RT20 + ELO5 – Research Peptide Blend (25mg)

Retatrutide 20mg + Eloralintide 5mg

RT20 + ELO5 is a dual-compound research blend combining retatrutide, an investigational triple-receptor agonist, with eloralintide, an investigational amylin-receptor agonist.

This combination is of scientific interest for studying metabolic regulation, appetite signaling, energy balance, and glucose metabolism.

Research Areas

Metabolic Research: Investigation of pathways involved in energy expenditure and metabolic regulation.

Appetite Signaling: Exploration of GLP-1, GIP, glucagon, and amylin receptor pathways.

Glucose Metabolism: Research into hormonal signaling associated with glucose regulation.

Combination Research: Investigation of interactions between incretin-related and amylin pathways.

Product Information

Product Name: RT20 + ELO5

Retatrutide: 20mg

Eloralintide: 5mg

Total Labeled Content: 25mg

Brand: 3A Labz

Important Notice

For laboratory research purposes only. Not for human consumption, injection, or clinical use.

Both compounds are investigational. The safety, effectiveness, and interactions of this specific combination have not been established. Product identity, purity, and potency require independent analytical verification.